Mortality for acute aortic dissection near one percent per hour during initial onset

March 10, 2013

The belief among medical professionals in the 1950s that the mortality rate for type A acute aortic dissection during the initial 24 hours was one to two percent per hour appears to hold true in the contemporary era of treatment, based on a review of the large-scale IRAD registry being presented March 9 at the American College of Cardiology (ACC) Scientific Sessions.

"In the 1950s, the suggested that the mortality rate for type A acute aortic dissection was one percent per hour, but we have limited information about the current rate in an era where advanced diagnostic imaging is often readily available," explains lead study author, Craig E. Strauss, MD, MPH, a research cardiologist at the Minneapolis Heart Institute Foundation and physician at the Minneapolis Heart Institute (MHI) at Abbott Northwestern Hospital in Minneapolis. "We reviewed data from the large-scale IRAD registry to obtain a real-world understanding of this patient population in the contemporary era."

The International Registry of Acute Aortic Dissections (IRAD) is a consortium of research centers, including MHI, which evaluates the management and outcomes of acute aortic dissection. Established in 1996, IRAD currently has 30 large referral centers in 11 countries participating in the registry.

"While aortic dissections are a less common diagnosis than a , present in a similar fashion with significant chest pain or back pain, and the is very real, which is why rapid and appropriate diagnosis and treatment is so important," says study co-author, Kevin Harris, MD, research at the Minneapolis Heart Institute Foundation.

An aortic dissection is a tear in the wall of the of the heart that allows blood to flow within the layers of the aorta. Early diagnosis and treatment of this illness is critical for survival. Certain types (type A) of dissections, if left untreated, kill 33% of patients within the first 24 hours, 50% of patients within 48 hours and 75% of patients within two weeks.

For this study, the researchers included 1,969 patients (mean age 61.1, 68.1% male) diagnosed with type A acute aortic dissection in IRAD between January 1996 and February 2012. Of those patients, 195 were managed medically, as opposed to receiving surgery.

The initial 24-hour mortality was higher for the medically managed group, compared with surgically managed patients, based on time from symptom onset (18.5% vs. 3.7%).

The mortality rate per hour during the initial 24 hours was 0.22% for all cases: 0.15% for surgically managed cases and 0.77% for medically managed cases. Among those patients managed medically, the rationale against surgery included age (41.7%), co-morbid illness (64.8%), patient refusal (27.1%), or other (21.3%).

"Essentially, we learned that the mortality rate for medically treated patients with acute hasn't changed significantly in the past 60 years, despite improvements in pharmacological treatment with beta-blockers and major advancements in tools," says Strauss. CT imaging is the most common method of diagnosis.

"The take-home message from our findings is that mortality is still extremely high for these patients, which calls for rapid diagnosis and rapid intervention through surgery," adds Harris, who is also co-director of the Program and director of the echocardiography laboratory at the Minneapolis Heart Institute¬ģ at Abbott Northwestern Hospital in Minneapolis. "These patients should not be medically managed throughout the night, for instance. If they are an appropriate candidate for surgery, they should be treated immediately."

Explore further: Simple new bedside screening effectively identifies patients with acute aortic dissection

Related Stories

Simple new bedside screening effectively identifies patients with acute aortic dissection

May 16, 2011
The most lethal and sudden cardiovascular event can be the toughest for doctors to diagnose.

Is it time for regional cardiovascular emergency care systems across the US?

April 25, 2012
Experts are proposing a new model of care collaboration to diagnosis, treat and follow patients who present with various emergent cardiovascular conditions which require rapid, resource-intensive care and confer a high risk ...

Study examines risk of aortic complications among patients with common congenital heart valve defect

September 13, 2011
While the incidence of the life-threatening condition of aortic dissection is significantly higher than in the general population, it remains low among patients with the congenital heart defect, bicuspid aortic valve; however, ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.